PI: Christopher Wheldon; Co-I: Sarah Bass
Funder: National Institute of Minority Health and Health Disparities
This application focuses on developing a clinic-based intervention to reduce anal cancer disparities in sexual and gender minority (SGM) populations, particularly among men who have sex with men (MSM) and transgender women (TGW). These groups face higher rates of anal cancer, but the HPV vaccine, which can prevent it, is underused by MSM/TGW. We aim to promote the HPV vaccine within the PrEP care system to reach more underserved MSM/TGW and help prevent anal cancer.
Our long-term goal is to create a toolkit for healthcare providers to guide shared decision-making about anal cancer prevention for MSM/TGW using PrEP. Currently, there is little research on how to effectively communicate anal cancer risks and prevention to diverse MSM/TGW populations. This study will focus on developing clear, relevant messages that meet the needs of MSM/TGW in PrEP care.